Lanreotide Interactions
There are 164 drugs known to interact with lanreotide, along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 4 are major, 148 are moderate, and 12 are minor.
- View all 164 medications that may interact with lanreotide
- View lanreotide alcohol/food interactions (1)
- View lanreotide disease interactions (7)
Most frequently checked interactions
View interaction reports for lanreotide and the medicines listed below.
- Ambien (zolpidem)
- Colace (docusate)
- Compazine (prochlorperazine)
- Creon (pancrelipase)
- Eliquis (apixaban)
- Farxiga (dapagliflozin)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flomax (tamsulosin)
- Jardiance (empagliflozin)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- Lithium Carbonate ER (lithium)
- Lovenox (enoxaparin)
- Lunesta (eszopiclone)
- Metoprolol Tartrate (metoprolol)
- Prozac (fluoxetine)
- Symbicort (budesonide / formoterol)
- Tylenol (acetaminophen)
- Valium (diazepam)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
- Zofran (ondansetron)
Lanreotide alcohol/food interactions
There is 1 alcohol/food interaction with lanreotide.
Lanreotide disease interactions
There are 7 disease interactions with lanreotide which include:
- hepatic impairment
- renal impairment
- thyroid abnormalities
- adrenal insufficiency
- bradycardia
- cholelithiasis
- diabetes
Report options
More about lanreotide
- lanreotide consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Sandostatin
Sandostatin is used to treat acromegaly and to reduce flushing episodes and watery diarrhea caused ...
Lutathera
Lutathera is a targeted radiotherapy used for gastroenteropancreatic neuroendocrine tumors ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Sandostatin LAR Depot
Sandostatin LAR Depot is used for acromegaly, carcinoid tumor, vasoactive intestinal peptide tumor
Cabozantinib
Cabozantinib systemic is used for hepatocellular carcinoma, neuroendocrine tumors, renal cell ...
Bromocriptine
Bromocriptine systemic is used for acromegaly, hyperprolactinemia, parkinson's disease, tardive ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Octreotide
Octreotide systemic is used for acromegaly, carcinoid tumor, diabetes, type 1, diarrhea, dumping ...
Somatuline Depot
Somatuline Depot is used as a long-term treatment for acromegaly. Learn about side effects ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
